中文名 | WYE-125132 (WYE-132) |
英文名 | WYE-125132 (WYE-132) |
别名 | MTOR抑制剂(WYE-125132) 1-(4-(4-(8-噁-3-氮杂双环[3.2.1]-3-辛基)-1-(1,4-二噁螺[4.5]-8-癸基)-1H-吡唑并[3,4-D]嘧啶-6-基)苯基)-3-甲基脲 N-[4-[1-(1,4-二氧杂螺[4.5]癸烷-8-基)-4-(8-氧杂-3-氮杂双环[3.2.1]辛烷-3-基)-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]-N'-甲基脲 |
英文别名 | WYE 125132 WYE 125132(WYE-132) WYE-125132 (WYE-132) N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea Urea, N-[4-[1-(1,4-dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methyl- 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyriMidin-6-yl)phenyl)-3-Methylurea WYE 125132 N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea WYE125132(WYE-132) |
CAS | 1144068-46-1 |
化学式 | C27H33N7O4 |
分子量 | 519.6 |
密度 | 1.55 |
熔点 | 162-184°C (dec.) |
溶解度 | DMSO (微溶) |
酸度系数 | 13.82±0.46(Predicted) |
存储条件 | -20°C Freezer |
外观 | 白色粉末固体。 |
颜色 | Off-White to Pale Beige |
体外研究 | WYE-125132 potently and ATP-competitively inhibits recombinant mTOR kinase with IC50 of 0.19 nM and also shows the high selectivity over various PI3Ks and a panel of 230 protein kinases. In vitro, WYE-125132 exhibits a significant anti-proliferative activity against a panel of tumor cell lines with IC50 ranging from 2 nM (LNCap) to 380 nM (HTC116). Besides, WYE-125132 also causes cell cycle progression, induction of apoptosis, and inhibition of protein synthesis and cell size. WYE-125132 results in a significant reduction in the synthesis of pre-tRNALeu by 72%, 80%, and 53% in actively proliferating cells of MG63, MDA361, and HEK293, respectively by inhibiting mTORC1. Moreover, WYE-125132 is also found to induce the dephosphorylation of Maf1 (negative regulator of Pol III transcription) and its accumulation in the nucleus. WYE-125132强效且ATP竞争性抑制重组mTOR激酶,IC50 为0.19 nM,选择性比作用于各种PI3Ks和230个蛋白激酶组高。在体外,WYE-125132对一组肿瘤细胞系表现出显著的抗增殖活性,IC50 范围为2 nM (LNCap) 到380 nM (HTC116)。此外,WYE-125132也会引起细胞周期进程,细胞凋亡诱导,以及蛋白合成和细胞大小的抑制。 WYE-125132通过抑制mTORC1引起pre-tRNA |
体内研究 | WYE-125132 (5 mg/kg p.o.) produces significant antitumor activity and causes dose-dependent tumor growth delay in the PI3K/mTOR- and HER2-hyperactive MDA361 tumor model. In addition, WYE-125132 also shows potent antitumor efficacy in the PTEN-null glioma U87MG, non-small cell lung cancer H1975 and A549 models. 在PI3K/mTOR- 和HER2-极度活跃的MDA361肿瘤模型中,WYE-125132(5 mg/kg p.o.)产生显著的抗肿瘤活性,并引起肿瘤生长剂量依赖性延缓。此外,WYE-125132在PTEN缺失的胶质瘤U87MG,非小细胞肺癌H1975 和A549模型中表现出有效的抗肿瘤活性。 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.925 ml | 9.623 ml | 19.245 ml |
5 mM | 0.385 ml | 1.925 ml | 3.849 ml |
10 mM | 0.192 ml | 0.962 ml | 1.925 ml |
5 mM | 0.038 ml | 0.192 ml | 0.385 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!